S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Bank Accounts: Frozen! (Ad)
Germany, EU reach agreement in combustion engine row
Intel co-founder, philanthropist Gordon Moore dies at 94
Bank Accounts: Frozen! (Ad)
Judge rules online archive's book service violated copyright
Biden's moves on Alaska drilling, TikTok test young voters
Bank Accounts: Frozen! (Ad)
Ruling halts oil exports from Iraq's Kurdish area via Turkey
Finnish leadership condemns attack on veteran lawmaker
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Bank Accounts: Frozen! (Ad)
Germany, EU reach agreement in combustion engine row
Intel co-founder, philanthropist Gordon Moore dies at 94
Bank Accounts: Frozen! (Ad)
Judge rules online archive's book service violated copyright
Biden's moves on Alaska drilling, TikTok test young voters
Bank Accounts: Frozen! (Ad)
Ruling halts oil exports from Iraq's Kurdish area via Turkey
Finnish leadership condemns attack on veteran lawmaker
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Bank Accounts: Frozen! (Ad)
Germany, EU reach agreement in combustion engine row
Intel co-founder, philanthropist Gordon Moore dies at 94
Bank Accounts: Frozen! (Ad)
Judge rules online archive's book service violated copyright
Biden's moves on Alaska drilling, TikTok test young voters
Bank Accounts: Frozen! (Ad)
Ruling halts oil exports from Iraq's Kurdish area via Turkey
Finnish leadership condemns attack on veteran lawmaker
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Bank Accounts: Frozen! (Ad)
Germany, EU reach agreement in combustion engine row
Intel co-founder, philanthropist Gordon Moore dies at 94
Bank Accounts: Frozen! (Ad)
Judge rules online archive's book service violated copyright
Biden's moves on Alaska drilling, TikTok test young voters
Bank Accounts: Frozen! (Ad)
Ruling halts oil exports from Iraq's Kurdish area via Turkey
Finnish leadership condemns attack on veteran lawmaker
NASDAQ:AXON

Axon Enterprise - AXON Stock Forecast, Price & News

$216.58
+0.86 (+0.40%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$212.38
$216.99
50-Day Range
$182.27
$222.24
52-Week Range
$82.49
$226.00
Volume
296,049 shs
Average Volume
1.01 million shs
Market Capitalization
$15.78 billion
P/E Ratio
106.17
Dividend Yield
N/A
Price Target
$221.64

Axon Enterprise MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.78 Rating Score
Upside/​Downside
2.3% Upside
$221.64 Price Target
Short Interest
Healthy
2.62% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.94mentions of Axon Enterprise in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$65.16 M Sold Last Quarter
Proj. Earnings Growth
58.76%
From $0.97 to $1.54 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.50 out of 5 stars

Industrial Products Sector

55th out of 179 stocks

Ordnance & Accessories, Except Vehicles & Guided Missiles Industry

2nd out of 5 stocks


AXON stock logo

About Axon Enterprise (NASDAQ:AXON) Stock

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Receive AXON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Axon Enterprise and its competitors with MarketBeat's FREE daily newsletter.

AXON Stock News Headlines

3 Security Stocks Benefiting From The Growing Public-Safety Trend
Security-related stocks are gathering steam on growing concern about public safety. These three stocks are rallying to new highs as they benefit from the trend.
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Body Camera Market forecast to 2028
Axon Enterprise Is Headed Higher: Here's How to Play It
StockNews.com Initiates Coverage on Axon Enterprise (NYSE:AXON)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Axon Appoints New Board Members
What 9 Analyst Ratings Have To Say About Axon Enterprise
Axon Enterprise Q4 2022 Earnings Preview
Axon Enterprise, Inc. (AXON)
Axon 2022 Revenue Grows 38% to $1.2 Billion
Axon Enterprise (AXON) Rose in Q4 on Revenue Guidance
See More Headlines
Receive AXON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Axon Enterprise and its competitors with MarketBeat's FREE daily newsletter.

AXON Company Calendar

Last Earnings
11/15/2021
Today
3/25/2023
Next Earnings (Estimated)
5/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Ordnance & accessories, except vehicles & guided missiles
Sub-Industry
Systems Software
Current Symbol
NASDAQ:AXON
Employees
3,734
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$221.64
High Stock Price Forecast
$263.00
Low Stock Price Forecast
$155.00
Forecasted Upside/Downside
+2.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

Net Income
$147.14 million
Pretax Margin
16.51%

Debt

Sales & Book Value

Annual Sales
$1.19 billion
Cash Flow
$1.40 per share
Book Value
$17.83 per share

Miscellaneous

Free Float
67,835,000
Market Cap
$15.78 billion
Optionable
Optionable
Beta
0.92

Key Executives

  • Patrick W. SmithPatrick W. Smith
    Chief Executive Officer & Director
  • Joshua M. IsnerJoshua M. Isner
    Chief Operating Officer
  • Brittany Bagley
    Chief Financial & Business Officer
  • Hans Moritz
    Vice President-Hardware Research & Development
  • Jenner Holden
    Chief Information Security Officer













AXON Stock - Frequently Asked Questions

Should I buy or sell Axon Enterprise stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axon Enterprise in the last twelve months. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AXON shares.
View AXON analyst ratings
or view top-rated stocks.

What is Axon Enterprise's stock price forecast for 2023?

9 equities research analysts have issued 12-month price objectives for Axon Enterprise's stock. Their AXON share price forecasts range from $155.00 to $263.00. On average, they anticipate the company's stock price to reach $221.64 in the next year. This suggests a possible upside of 2.3% from the stock's current price.
View analysts price targets for AXON
or view top-rated stocks among Wall Street analysts.

How have AXON shares performed in 2023?

Axon Enterprise's stock was trading at $165.93 on January 1st, 2023. Since then, AXON shares have increased by 30.5% and is now trading at $216.58.
View the best growth stocks for 2023 here
.

When is Axon Enterprise's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023.
View our AXON earnings forecast
.

How were Axon Enterprise's earnings last quarter?

Axon Enterprise, Inc. (NASDAQ:AXON) released its quarterly earnings data on Monday, November, 15th. The biotechnology company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.91. The biotechnology company earned $231.99 million during the quarter, compared to analysts' expectations of $201.11 million. Axon Enterprise had a trailing twelve-month return on equity of 12.70% and a net margin of 12.36%. The business's revenue for the quarter was up 39.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.01) earnings per share.

What guidance has Axon Enterprise issued on next quarter's earnings?

Axon Enterprise issued an update on its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.43B-, compared to the consensus revenue estimate of $1.38 billion.

What other stocks do shareholders of Axon Enterprise own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axon Enterprise investors own include Novavax (NVAX), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Micron Technology (MU), TherapeuticsMD (TXMD), ACADIA Pharmaceuticals (ACAD), bluebird bio (BLUE) and Arena Pharmaceuticals (ARNA).

When did Axon Enterprise IPO?

(AXON) raised $251 million in an IPO on Thursday, June 11th 2015. The company issued 17,900,000 shares at a price of $13.00-$15.00 per share. Jefferies, Evercore ISI and RBC Capital Markets served as the underwriters for the IPO and JMP Securities and Baird were co-managers.

What is Axon Enterprise's stock symbol?

Axon Enterprise trades on the NASDAQ under the ticker symbol "AXON."

Who are Axon Enterprise's major shareholders?

Axon Enterprise's stock is owned by a number of institutional and retail investors. Top institutional investors include Baillie Gifford & Co. (3.49%), William Blair Investment Management LLC (2.40%), Morgan Stanley (1.98%), Franklin Resources Inc. (1.61%), Alliancebernstein L.P. (1.42%) and Conestoga Capital Advisors LLC (1.38%). Insiders that own company stock include Adriane M Brown, Caitlin Elizabeth Kalinowski, Hadi Partovi, Jawad A Ahsan, Jeffrey C Kunins, Joshua Isner, Julie A Cullivan, Luke Larson, Mark W Kroll, Matthew R Mcbrady, Matthew R Mcbrady, Michael Garnreiter and Patrick W Smith.
View institutional ownership trends
.

How do I buy shares of Axon Enterprise?

Shares of AXON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Axon Enterprise's stock price today?

One share of AXON stock can currently be purchased for approximately $216.58.

How much money does Axon Enterprise make?

Axon Enterprise (NASDAQ:AXON) has a market capitalization of $15.78 billion and generates $1.19 billion in revenue each year. The biotechnology company earns $147.14 million in net income (profit) each year or $2.04 on an earnings per share basis.

How many employees does Axon Enterprise have?

The company employs 3,734 workers across the globe.

How can I contact Axon Enterprise?

Axon Enterprise's mailing address is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. The official website for the company is www.axovant.com. The biotechnology company can be reached via phone at (480) 991-0797, via email at ir@axon.com, or via fax at 480-991-0791.

This page (NASDAQ:AXON) was last updated on 3/26/2023 by MarketBeat.com Staff